Loading

August, 2009

  • by Allen St. Pierre, NORML Executive Director August 8, 2009

    In an attempt to clarify an apparent gaffe made a few weeks ago to California media stating that “marijuana is dangerous and has no medicinal value”, drug czar Gil Kerlikowske in a new interview with his hometown media in Seattle has only slightly, almost imperceptibly, modified his remarks by now implying that somehow how ‘smoked‘ medical cannabis is not a legitimate and effective drug delivery method:

    When asked about his comments a few weeks ago Kerlikowske told KOMO news “I certainly said that legalization is not in the president’s vocabulary nor is it in mine. But the other question was in reference to smoked marijuana. And as we know, the FDA has not determined that smoked marijuana has a value, and this is clearly a medical question that should be answered by the medical community.”

    KOMO also reports:

    Kerlikowske’s stand on legalizing marijuana for everyone is more clear-cut. The Office of National Drug Control Policy, by law, actively works against legalizing drugs.

    Kerlikowske takes on last jab at cannabis by continuing his predecessor’s  proclivity to mislead the media and public by claiming “You know from the University of Washington, the number one call from young people for treatment here, after alcohol, is marijuana. So I’m not seeing the benefit to society with legalization here.”

    Number one, cannabis is not legal in Washington state, or anywhere in the US, 2) youth in Washington, and all around the US, after being ensnared by the hundreds of thousands per year by cannabis prohibition laws enforced by the criminal justice system (or university police), are provided with the Hobson’s Choice of either going to jail or so-called ‘treatment’.

    Mr. Kerlikowske should cease employing this rhetorical straw man as he is intelligent enough to know its inaccuracy, but continues to adopt the failed rhetoric of prior hardliner drug czars Gen. Barry McCaffrey and John Walters, who consistently made the same claims during their tenure, and lost credibility every time they continued to propound such obviously misleading propaganda.

    Kerlikowske’s latest unfortunate remarks affirm cannabis law reformers have much work left to do! Maybe our good drug czar should call actor Patrick Swayze and ask him ‘if he is benefiting from smoked medical cannabis?’

    Patrick Swayze, who was diagnosed with pancreatic cancer over a year ago, is using medical marijuana to relieve the pain of his last days of chemotherapy.

    According to a family insider, Swayze, 56, has found that smoking marijuana helps with his nausea, inability to sleep, and anxiety. The insider noted on the actor’s slight weight gain as well as adding that he (Swayze) feels more “normal than he has in months.”

    Pictures have surfaced of Swayze out with his brother Donnie looking much healthier than he had weeks before.

    “Patrick was rapidly losing weight because he couldn’t keep good down. He was so weak, he needed help getting around,” the source told the magazine.

    “Marijuana works extremely well for many cancer patients. It helps fight nausea from chemotherapy treatments and may alleviate anorexia or loss of appetite,” Dr. Ron Kennedy of Santa Rosa, CA, said of the situation.

  • by Paul Armentano, NORML Deputy Director August 6, 2009

    Many years ago the former head of the U.S. National Institute on Drug Abuse (NIDA) Alan Leshner made this statement when forced to confront the fact that tens of thousands of patients were successfully using cannabis as a medicine:

    “The plural of anecdote is not evidence.”

    Someone ought to pass on Lesnher’s cop out to ABC News, whose recent feature, “Reefer Madness Redux: Is Pot Addictive?“, is little more than a series of anecdotes from folks claiming that it’s becoming harder and harder for some individuals to quit weed.

    Here’s a typical example:

    The biggest hurdle in treating these patients is that marijuana “still has a positive spin to it,” he said. “People don’t believe it’s a problem.”

    “Plenty believe that they can’t get addicted or hold on to the idea that it’s only psychologically addictive and ‘I can think my way out of it,’”said Massella. “But once you develop a dependency, there is always a dependency.”

    Naturally, John Massella, like many of the so-called experts quoted in the ABC story, has a financial incentive to promote the “marijuana is seriously addictive” claim. After all, he runs a drug rehabilitation center. Claiming that many of his clients are “pot addicts” is far more socially acceptable than admitting that most of his so-called ‘marijuana treatment admissions’ are really just young people who were busted for pot possession and ordered there by the court as a condition of probation.

    But putting the anecdotes aside, what does the science actually say about pot and dependence?

    Well, according to the nonpartisan National Academy of Sciences’ Institute of Medicine — which published a multiyear, million-dollar federal study assessing marijuana and health in 1999 — “millions of Americans have tried marijuana, but most are not regular users [and] few marijuana users become dependent on it.” The agency added, “[A]though [some] marijuana users develop dependence, they appear to be less likely to do so than users of other drugs (including alcohol and nicotine), and marijuana dependence appears to be less severe than dependence on other drugs.” (In fact, more recent research indicates that marijuana use may actually help some people kick their hard drug habits!)

    Just how less likely? According to the IOM’s 267-page report, fewer than 10 percent of those who try cannabis ever meet the clinical criteria for a diagnosis of “drug dependence” (based on DSM-III-R criteria). By contrast, the IOM reported that 32 percent of tobacco users, 23 percent of heroin users, 17 percent of cocaine users and 15 percent of alcohol users meet the criteria for “drug dependence.” In short, it’s the legal drugs that have Americans hooked — not pot. (more…)

  • by Allen St. Pierre, NORML Executive Director August 5, 2009

    From today’s Washington Post’s Reliable Sources:

    It was only a matter of time before someone combined a certain memorable image of a young future president with a jokey twist on his campaign slogan … to come up with a message that Barack Obama definitely did not approve.

    norml_poster_sm

    The folks at the National Organization for the Reform of Marijuana Laws got there first. For their annual conference poster, they took an old photo of cool-dude college freshman Obama puffing away — on a regular cigarette, mind you — and tweaked it just ever so slightly to fit their message: “Yes We Cannabis.”

    Think it might be a problem for the president (who opposes legalization)? It’s really a problem for the photographer. Lisa Jack, an Obama classmate at Occidental College, snapped the image in 1980, one in a series of photos that never saw the light of day until she debuted them in Time’s 2008 Person of the Year issue. She had no idea her photo had been appropriated by NORML until we told her Tuesday.

    “They do not have my permission,” said Jack, a psychology professor in Minnesota. These photos “are absolutely not to be used in this way. … I really made a grand effort to do this properly, and I’m very irritated. If I’d wanted these to be used for political purposes, I’d have sold them to Hillary years ago.”

    NORML Executive Director Allen St. Pierre cheerfully acknowledged the lift by artist Sonia Sanchez, who summoned the psychedelic aesthetic of ’60s rock posters. “With very little adulteration, she placed what appears to be a cannabis cigarette” in the president’s hand, St. Pierre said. But she made few other changes: Obama “almost made the photograph for us.”

    Everyone who attends the September conference in San Francisco will get a poster; NORML is also selling them on the Web ($25 for an 18-by-24-inch with St. Pierre’s autograph, $15 without). Can they do that? St. Pierre admits they didn’t get permission, but “our lawyers thought it was adulterated enough to comply with the fair use laws.”

    We’ll see. Shepard Fairey made more dramatic changes to the Obama photo he turned into the now-famous “HOPE” collage — but he’s still embroiled in bitter litigation with the Associated Press, which owns the original image. The AP accused him in federal court of “blatant copying.” And yes, Jack has already called the lawyers for Getty Images, which oversees her photo’s copyright.

    Jack, whose photos now have a gallery show in L.A., grudgingly admits “it’s really cool” that the images are already iconic enough to steal. She’d love to see Fairey do a work-up on them — with permission, of course.

    A brief history about the series of Obama photos is found at The Huffington Post.

  • by Allen St. Pierre, NORML Executive Director August 4, 2009

    This informative article from CBS News about the government’s claim that there is no need for medical patients to access cannabis, when there is a ‘fake’ cannabis pill on the market, features remarks from NORML advisory board member, professor and author

    Mitch Earleywine, and former deputy drug czar under Bush 1.0 Herb Kleber, which strongly underlines the differences between credible and not credible on the topic of cannabis.

    Credible:

    [One] problem with Marinol is that it’s orally administered,” Dr. Mitch Earleywine, an associate professor of Clinical Psychology at the State University of New York at Albany, said in an email. “Therefore, it takes longer to work than cannabis inhaled from a vaporizer. (Usually 90 minutes at best rather than 15 seconds – a meaningful amount of time to the nauseated.)”

    “It’s harder to control dosage, too, so folks end up discombobulated or without symptom relief,” he added. “In addition, folks who are vomiting can’t hold down the pills.” Earleywine also said that a dose Marinol costs three to five times as much as a comparable dose of medical marijuana.

    Not Credible:

    “Are there actions in the whole plant that you don’t get from just the Marinol? I would be surprised if there wasn’t,” he continued. “The problem is that most of the data about the potential medical actions of the smoked form are anecdotal.”

    Dr. Kleber, who said he has prescribed Marinol to a patient and found it to be effective, points to what he characterizes as a significant advantage of the pill over traditional marijuana: “People don’t abuse it.”

    “Marijuana addiction is becoming common and as a result I’m seeing an increasing number of people who have trouble stopping marijuana,” he said. “Contrary to popular beliefs that there is no marijuana withdrawal, there is marijuana withdrawal. It’s very clear cut.”

    Talk about anecdotal! Dr. Kleber would have readers believe, that cannabis today, as compared to the prior 2,000 years of documented cannabis use by humans is that “Marijuana addiction is becoming common”.

    Really?

    “I’m seeing an increasing number of people who have trouble stopping marijuana”

    Of course you are Herb because as it has been well documented by NORML that the criminal justice system throughout most of the United States presents minor cannabis offenders with the Hobson’s Choice of either going to jail or to visit the offices of the ‘Dr. Klebers’ in America for ‘treatment’.

    Dr. Kleber well knows this, so his statement is for me the working definition of disingenuous!

    Lastly, there is nothing new about Marinol as it has been legal and available for medical patients since the mid 1980s. If the pill worked as Dr. Kleber claims, voters and legislators in the 13 states with medical cannabis laws would not have opted for a whole plant solution.

    Marinol was supposed to be the government’s great ‘silver bullet’ back in the mid 1980s to end the public debate about patients’ need for whole-smoked cannabis–an analog of one of the plant’s major ingredients isolated in pill form.

    Want to know more about ‘pot’ pills vs. the real thing? Checkout NORML’s published paper ‘Marinol vs. Natural Cannabis‘.

    Does the Pot Pill Work?
    The Government Says a Pill Called Marinol Offers the Same Benefits as
    Medical Marijuana. Is it True?

    By Brian Montopoli
    August 4, 2009

    (CBS) “Medical marijuana,” the U.S. Drug Enforcement Administration says, “already exists.”

    They don’t just mean in California. A pill known as Marinol has been legal and approved by the Food and Drug Administration for use with a prescription anywhere in America since 1985.

    It’s active ingredient? Dronabinol, better known as THC, the primary psychoactive element of the cannabis plant.

    “Marinol provides standardized THC concentrations, does not contain the other 400 uncharacterized substances found in smoked marijuana, such as carcinogens or fungal spores, and is not associated with the quick high of smoked marijuana,” said Neil Hirsch, a spokesman for Marinol manufacturer Solvay Pharmaceuticals.

    But Marinol is not the same thing as traditional, smokable marijuana. It is a less complex substance lacking both some of the good components found in traditional marijuana (such as cannabidiol, which has been found to have anti-seizure effects) and the bad or not-yet-fully-understood components (among them potential carcinogens) that can also come with the drug.

    Ken Trainer, a 60-year-old Massachusetts resident who has battled Multiple Sclerosis for 25 years, said he has long been smoking marijuana to deal with the regular tremors he gets in his arms and legs.

    “If I smoke a joint, the tremors go away most times before the joint is gone,” he said. “It makes my life a little easier.” Marinol, by contrast, “didn’t really do much of anything for me,” he said.

    56-year-old Des Moines resident Jeff Elton, who was diagnosed with gastroparesis six years ago, had a similar experience when he was prescribed Marinol to deal with his chronic nausea and vomiting.

    “I felt no relief, I didn’t feel ill, I felt nothing,” he said. “It might as well be M&M’s.”

    Elton said he switched to marijuana, which he smokes through a vaporizer – a device that heats the active ingredients into a vapor instead of burning them. He said it allows him to keep down his food and regain some of the weight he lost while on Marinol. (more…)

  • by Russ Belville, NORML Outreach Coordinator August 3, 2009

    Marijuana legalization is the hottest topic in the media these days. MSNBC, CNBC, CNN, FOX, NatGeo, and CBS News have presented special features on marijuana business, medical marijuana, and the marijuana legalization movement. Google Trends is showing double the interest in searches and news hits for the term “marijuana legalization”. Showtime’s hit series Weeds, about a suburban mom turned pot dealer, is entering its fifth season. Everywhere you look, corporate media are happy to profit from America’s most popular herb.

    Unless you want to address marijuana’s illegality and the lives that are shattered by the effects of marijuana prohibition. In that case, the corporate media cannot have anything to do with you, even if you want to pay to broadcast the message of ending adult marijuana prohibition. (more…)

  • by Allen St. Pierre, NORML Executive Director August 1, 2009

    A medical billing company may be blowing smoke, but could reimbursing patients for medical marijuana lower drug costs for employers?
    By Jeremy Smerd, Workforce Management Online, July 2009

    In mid-June, Rhode Island became the third state to legalize the sale of marijuana for medical use, giving momentum to advocates who believe the legalization of the drug offers a dose of sanity for the nation’s costly health care system.

    Now that more states are legalizing the sale of the marijuana used solely as a medicine, the next hurdle for reformers who say the drug is more cost-effective than pharmaceuticals is getting those who pay for health care—insurers and employers—to reimburse patients for its use.

    “It’s going to take an employer that says, ‘We’re not interested in marijuana as a gateway drug or any of that reefer madness. We want to talk about dollars and cents,’ ” says Allen St. Pierre, executive director of NORML (the National Organization for the Reform of Marijuana Laws). “If the idea here is saving money, then there’s no question that medical marijuana should be part of the ambit of choices that doctors, patients and employers can have.”

    The effort to legalize the sale of medical marijuana has focused mainly on whether the medical effectiveness of the drug justifies making it legal to obtain in plant form. The medical benefits have been most closely tied to treating weight loss, nausea, pain, inflammation, spasticity and other symptoms associated with cancer, AIDS, cerebral palsy, muscular dystrophy and arthritis.

    Advocates for its legalization say its medical benefits should be made available to ease the suffering of patients. In a nod to the plant’s medicinal powers, pharmaceutical companies have produced synthetic forms of some of its active chemicals.

    Less attention, though, has been focused on whether paying for patients’ medical marijuana is a cost-effective way to manage certain illnesses. Advocates argue that marijuana is an effective medicine that can also be a cost-effective alternative to pharmaceuticals.

    Reimbursing patients who use it could push them away from otherwise costly drugs that some advocates say are not as effective. Employers, as payers of health care, should champion the legalization of medical marijuana as a potential cost-saving tool, advocates say.

    Despite the recent legislative victories, however, even employers that want to reimburse patients who use medical marijuana cannot.

    Stephen DeAngelo, chief executive of Harborside Health Center, a medical marijuana dispensary in Oakland, California, has tried to provide a medical marijuana benefit through the health plan he provides to his 67 full-time employees.

    “Blue Cross Blue Shield will not reimburse for medical marijuana; we checked,” he says. “It’s illegal under federal law and they can’t do anything that will break federal law.” Instead, he provides his employees, all of whom are medical marijuana patients, with a free gram of marijuana for every shift they work, a policy he says has lowered his company’s health insurance costs. “Many of these patients had drug bills of several hundred dollars a week before they began using medical marijuana,” he says. “Now they are about $40 or $50 a week.” (more…)

Page 3 of 3123